Fellow, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC.
Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC.
Obstet Gynecol Surv. 2014 Sep;69(9):557-63. doi: 10.1097/OGX.0000000000000106.
Sutures, hemoclips, and electrocautery are the primary mechanisms used to achieve hemostasis during gynecologic surgery, but in situations in which these are inadequate or not feasible, an array of hemostatic agents are available to help achieve hemostasis. These agents include physical agents such as cellulose, collagen, or gelatin products as well as biologic agents such as thrombin and fibrin products. Limited data are available on many of these agents, although their use is increasing, sometimes at high costs. In gynecologic surgery, hemostatic agents are likely most effective when used in areas of oozing or slow bleeding and as an adjunct to conventional surgical methods of hemostasis.
缝合线、血管夹和电烙术是妇科手术中实现止血的主要机制，但在这些方法不充分或不可行的情况下，有一系列止血剂可用于帮助实现止血。这些止血剂包括物理剂，如纤维素、胶原蛋白或明胶制品，以及生物剂，如凝血酶和纤维蛋白制品。虽然这些止血剂的使用越来越多，有时成本很高，但关于许多止血剂的数据有限。在妇科手术中，止血剂在渗血或缓慢出血区域最有效，并且可以作为传统止血方法的辅助手段。
